Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria

Rachel S. van der Post(Radboud University Nijmegen), Annemieke Cats(Oncode Institute), Tanya M. Bisseling(Radboud University Nijmegen), Anna Grelack(Radboud University Nijmegen), Iris Lansdorp‐Vogelaar(Erasmus University Rotterdam), Pétur Snæbjörnsson(University of Iceland), Jolanda van Dieren(The Netherlands Cancer Institute), Lizet E. van der Kolk(The Netherlands Cancer Institute), J. Han van Krieken(Radboud University Nijmegen)

Gastrointestinal Endoscopy

April 25, 2017

10.1016/j.gie.2017.04.016

Cited by 28

Related Papers

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936

|Leukemia|2003|3k

Genome-wide cell-free DNA fragmentation in patients with cancer

|Nature|2019|1.5k

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

|Nature Genetics|2008|818

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

|The Lancet Oncology|2018|582